European Pharmaceutical Review

OCTOBER 24, 2022

Three trade bodies representing vaccine creators and manufacturers are endorsing The Berlin Declaration framework , a proposal that outlines how the industry would reserve an allocation of real-time vaccine production for swift distribution to priority populations in lower-income countries in future pandemics.

Distribution 65

Distribution Manufacturing Pharmaceutical manufacturing Networking 65

European Pharmaceutical Review

JULY 21, 2023

In this Q&A EPR speaks to Naser Al Yammahi the Deputy CEO of Hayat Biotech about pharmaceutical supply chain challenges and how they can be addressed. Yammahi was instrumental in building Hayat’s extensive distribution network needed to supply vaccines during the COVID-19 pandemic.

Pharmaceutical 95

Pharmaceutical Food and Drug Administration Transportation Manufacturing 95

Pharmaceutical Technology

SEPTEMBER 6, 2022

The pharmaceutical supply chain is a global and complex network that includes a wide range of stakeholders such as pharmaceutical manufacturers, wholesale distributors, and pharmacy benefit managers (PBM), to ensure efficient and timely delivery of medications to the patients.

Pharmaceutical 59

Pharmaceutical Leads Pharma Transportation 59

European Pharmaceutical Review

SEPTEMBER 28, 2023

When questioned about which technologies he considered have potential to advance the sector, Chornet emphasised that not only is mRNA as a vaccine technology “a very promising and interesting platform [but that it is] disruptive and a game changer technology for vaccine [manufacturing] and overall biotech.”

Manufacturing 85

Manufacturing Government Pharmaceutical manufacturing Pharmaceutical 85

PM360

OCTOBER 25, 2023

Therefore, when the initiator owns all components of the combination, greater flexibility is possible as negotiations can occur simultaneously across components and can influence the distribution of discounts across products. JAMA Network Open 5 , no. Certain markets (e.g., References: 1. Benjamin, Alexander Xu, Mark P. 2022.2265.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Marketing Pharmaceutical manufacturing 105

pharmaphorum

DECEMBER 16, 2022

Ben Hargreaves discovers why some have referred to the distribution of COVID-19 vaccines and treatments as a form of apartheid. Further, with a pandemic treaty in development, there are reasons to believe that many countries and the WHO want to see a more equitable distribution of medical products for future pandemics.

Distribution 68

Distribution Pharmaceutical manufacturing Manufacturing Pharmaceutical 68

European Pharmaceutical Review

JULY 25, 2022

Consequently, pharmaceutical manufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. Criminal networks are penetrating established digital and ecommerce channels, benefitting from their trusted authenticity and authority to distribute fake products to unsuspecting patients.

Pharmaceutical 85

Pharmaceutical Medicine Pharmaceutical manufacturing Manufacturing 85